Table 1.
Patient Characteristics Table
| Benign (N=50) |
Early Stage (N=50) |
Advanced Stage (N=100) |
Total (N=200) |
|
|---|---|---|---|---|
| Age at Diagnosis | ||||
| Median | 60.5 | 54.5 | 63.0 | 60.0 |
| Q1, Q3 | 49.0, 69.0 | 50.0, 69.0 | 54.0, 69.5 | 50.5, 69.0 |
| Range | (38.0–82.0) | (35.0–82.0) | (36.0–81.0) | (35.0–82.0) |
| CA-125 | ||||
| Median | 10.4 | 160.1 | 1043.9 | 219.8 |
| Q1, Q3 | 8.0, 17.1 | 43.8, 735.8 | 354.2, 3220.8 | 22.1, 1552.5 |
| Range | (5.1–552.7) | (7.9–7264.8) | (16.3–19131.6) | (5.1–19131.6) |
| Histology | ||||
| Serous | 0 (0.0%) | 14 (28.0%) | 81 (81.0%) | 95 (47.5%) |
| Mucinous | 0 (0.0%) | 6 (12.0%) | 0 (0.0%) | 6 (3.0%) |
| Endometrioid | 0 (0.0%) | 13 (26.0%) | 9 (9.0%) | 22 (11.0%) |
| Clear cell | 0 (0.0%) | 9 (18.0%) | 4 (4.0%) | 13 (6.5%) |
| Mixed Epithelial | 0 (0.0%) | 8 (16.0%) | 6 (6.0%) | 14 (7.0%) |
| Benign | 50 (100.0%) | 0 (0.0%) | 0 (0.0%) | 50 (25.0%) |
| Ascites | ||||
| Yes | NA | 12 (24.0%) | 59 (59.0%) | 71 (47.3%) |
| No | NA | 34 (68.0%) | 23 (23.0%) | 57 (38.0%) |
| Unknown | NA | 4 (8.0%) | 18 (18.0%) | 22 (14.7%) |
| Debulking | ||||
| Optimal | NA | 49 (98.0%) | 88 (88.0%) | 137 (91.3%) |
| Sub-optimal | NA | 0 (0.0%) | 9 (9.0%) | 9 (6.0%) |
| Unknown | NA | 1 (2.0%) | 3 (3.0%) | 4 (2.7%) |
| Stage | ||||
| I | NA | 36 (72.0%) | 0 (0.0%) | 36 (24.0%) |
| II | NA | 14 (28.0%) | 0 (0.0%) | 14 (9.3%) |
| III | NA | 0 (0.0%) | 83 (83.0%) | 83 (55.3%) |
| IV | NA | 0 (0.0%) | 17 (17.0%) | 17 (11.3%) |
| Grade | ||||
| Missing | NA | 1 | 3 | 4 |
| Low | NA | 16 (32.7%) | 7 (7.2%) | 23 (15.8%) |
| High | NA | 33 (67.4%) | 90 (92.8%) | 123 (84.2%) |